Recombinant Human TXNL4B Protein，GST

VMO1, or Vascular Smooth Muscle Cell-Associated Protein 1, is a pivotal protein that has garnered significant attention in recent years due to its potential roles in vascular biology and disease. Initially identified as a protein expressed in vascular smooth muscle cells, VMO1 has been implicated in various physiological and pathological processes, including smooth muscle differentiation, proliferation, and apoptosis. Research indicates that VMO1 may play a crucial role in the development and progression of cardiovascular diseases, such as atherosclerosis and hypertension, by influencing vascular tone and remodeling. The understanding of VMO1's molecular mechanisms is further bolstered by its association with the regulation of several signaling pathways linked to cell growth and survival. Recent studies have aimed at elucidating the structure-function relationship of VMO1, as well as its interactions with other proteins, to provide insights into its biological significance. Moreover, the use of recombinant VMO1 protein in experimental studies presents an opportunity to explore therapeutic interventions that modulate its activity, potentially paving the way for novel approaches to treating vascular disorders. As the research community continues to unravel the complexities surrounding VMO1, this protein stands at the forefront of investigations aimed at understanding vascular health and developing effective cardiovascular therapies.